Andrew Perry
Corporate Officer/Principal en G1 THERAPEUTICS, INC. .
Fortuna: 304 751 $ al 30/04/2024
Perfil
Andrew Perry is currently the Chief Commercial Officer at G1 Therapeutics, Inc. He previously worked as the Vice President of US Marketing at ViiV Healthcare Ltd.
Mr. Perry is a graduate of the University of Glasgow and The University of Sheffield.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
G1 THERAPEUTICS, INC.
0.15% | 13/05/2024 | 78 951 ( 0.15% ) | 304 751 $ | 30/04/2024 |
Cargos activos de Andrew Perry
| Empresas | Cargo | Inicio |
|---|---|---|
| G1 THERAPEUTICS, INC. | Corporate Officer/Principal | 02/08/2021 |
Antiguos cargos conocidos de Andrew Perry.
| Empresas | Cargo | Fin |
|---|---|---|
ViiV Healthcare Ltd.
 ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology ViiV Healthcare Ltd. manufactures and distributes pharmaceutical products. Its medicine include Triumeq, Tivicay, Selzentry, Celesentri, Epzicom, Kivexa, Ziagen, Trizivir, Combivir, Retrovir AZT, Lexiva, Telzir, Viracept and Rescriptor. The company was founded in 2009 and is headquartered in Brentford, the United Kingdom. | Corporate Officer/Principal | - |
Formación de Andrew Perry.
| University of Glasgow | Graduate Degree |
| The University of Sheffield | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| G1 THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
ViiV Healthcare Ltd.
ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology ViiV Healthcare Ltd. manufactures and distributes pharmaceutical products. Its medicine include Triumeq, Tivicay, Selzentry, Celesentri, Epzicom, Kivexa, Ziagen, Trizivir, Combivir, Retrovir AZT, Lexiva, Telzir, Viracept and Rescriptor. The company was founded in 2009 and is headquartered in Brentford, the United Kingdom. | Health Technology |
- Bolsa de valores
- Insiders
- Andrew Perry
